Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Haemonetics (HAE) Shares Issued (2016 - 2025)

Haemonetics has reported Shares Issued over the past 17 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Shares Issued at $1.1 million for Q4 2025, up 127.13% from a year ago — trailing twelve months through Dec 2025 was $2.2 million (up 19.48% YoY), and the annual figure for FY2024 was $1.6 million, down 38.97%.
  • Shares Issued for Q4 2025 was $1.1 million at Haemonetics, up from $63000.0 in the prior quarter.
  • Over the last five years, Shares Issued for HAE hit a ceiling of $2.4 million in Q2 2021 and a floor of $63000.0 in Q3 2025.
  • Median Shares Issued over the past 5 years was $462000.0 (2025), compared with a mean of $650210.5.
  • Biggest five-year swings in Shares Issued: surged 1519.7% in 2021 and later tumbled 86.27% in 2022.
  • Haemonetics' Shares Issued stood at $1.1 million in 2021, then crashed by 85.03% to $160000.0 in 2022, then grew by 16.25% to $186000.0 in 2023, then surged by 171.51% to $505000.0 in 2024, then skyrocketed by 127.13% to $1.1 million in 2025.
  • The last three reported values for Shares Issued were $1.1 million (Q4 2025), $63000.0 (Q3 2025), and $462000.0 (Q2 2025) per Business Quant data.